s6y
Company name or ticker
Search
BRAINSTORM CELL THERAPEUTICS INC.
DEF 14A
Definitive proxy statements
Filed
Thursday, September 14, 2017
Period
Nov 9, 2017
Accession number
0001144204-17-048051
Documents
DEF 14A
DEF 14A
On sec.gov
Filing index
All files
Complete submission text
SGML header